Life Science Pharma Articles & Analysis
9 news found
Sagaert joined etherna in 2017 and brings extensive operational and strategic experience in the life sciences industry. Dekkers, who is the founder of investment and advisory firm Novalis Capital Partners LLC and former CEO of Bayer AG and Thermo Fisher Scientific, is widely recognized as a visionary industry leader. ...
ByeTheRNA
Based in Cambridge, MA, Optibrium Inc. sits in a vibrant life sciences network of biotech and pharma companies. The headcount of Optibrium’s US-based team has doubled over the course of 2022, and the opening of Optibrium Inc. will further enable this rapid growth trajectory and create additional recruitment opportunities, including business ...
Ariana Pharma, the eXplainable Artificial Intelligence clinical development Company, announced today the presentation of Phase 2 clinical biomarker data from the ANAVEX2-73-PDD-001 Parkinson’s Disease Dementia (PDD) study at the AD/PD 2022 International Conference. MDS-UPDRS Total score improved significantly for patients treated with ANAVEX®2-73 high oral once-daily dose compared to ...
Thermo Fisher Scientific, the world leader in serving science, today announced it has won six awards in the annual CMO Leadership Awards. The awards, presented by Life Science Leader and Outsourced Pharma, recognize top contract manufacturing partners as evaluated by biopharma and biotech companies. ...
(NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing ...
The new directors all have international experience in leading pharma and life sciences businesses. Their arrival follows the recent £2.75m investment in Invizius by a consortium of investors including Mercia, Downing Ventures, the University of Edinburgh’s Old College Capital fund and the Scottish Investment Bank, the investment arm ...
Third Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, has named seasoned healthcare executive Bill Athenson as its new Chief Executive Officer, the company announced today. ...
As part of this, we are confirming a portfolio management programme to review and/or exit markets which do not offer attractive long-term growth and returns, putting greater focus on markets where we are strong, such as Pharma, Life Sciences and TMT, amongst ...
ByInforma
The current businesses compose the new core of DSM in Life Sciences and Materials Sciences.DSM's focus on Life Sciences (Nutrition and Pharma) and Materials Sciences (Performance Materials and Polymer Intermediates) is fueled by three societal trends: Global Shifts, Climate and Energy and Health ...